Vimarsana
Biggest News Aggregation in the World

Page 11 - Exome Sequencing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exome Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exome Sequencing Today - Breaking & Trending Today

Neuberg Diagnostics launches NCGM, its first Laboratory in the USA - Vimarsana News

Neuberg Diagnostics launches NCGM, its first Laboratory in the USA

Press release content from PR Newswire. The AP news staff was not involved in its creation. Neuberg Diagnostics launches NCGM, its first Laboratory in the USA May 3, 2021 GMT ~ Unites key collaborators under one umbrella for molecular and genomics based new generation testing ~ RALEIGH, N.C, May 3, 2021 /PRNewswire/ -- Neuberg Diagnostics, a global laboratory testing group, announced the start of its clinical laboratory operations in North Carolina in the United States of America (USA). The laboratory in North Carolina, known as NCGM, Inc. (Neuberg Centre for Genomic Medicine), will focus on ...

Source: apnews.com
Study reveals why intellectual disability risk for younger sib­lings is low - Vimarsana News

Study reveals why intellectual disability risk for younger sib­lings is low

Study reveals why intellectual disability risk for younger sib­lings is low Intellectual disability is most often caused by changes to the genome that take place in early fetal development and are not found in the parents’ DNA. This is why the risk of recurrence in the next sibling of the family is very small, as indicated by a study conducted at the University of Helsinki. Furthermore, Finns do not have a higher risk of inherited developmental disorders compared to other Europeans. The prevalence of intellectual disabilities, which means difficulties with learning and understanding new th...

Somatic gene mutations in brain cells could contribute to schizophrenia pathology - Vimarsana News

Somatic gene mutations in brain cells could contribute to schizophrenia pathology

Schizophrenia is a neurodevelopmental disorder that disrupts brain activity producing hallucinations, delusions, and other cognitive disturbances. Researchers have long searched for genetic influences in the disease, but genetic mutations have been identified in only a small fraction--fewer than a quarter--of sequenced patients.

Worldwide Industry for Neurologic Condition Genetic Testing to 2025 - Featuring Ambry Genetics, Arup Laboratories & Asuragen Among Others - Vimarsana News

Worldwide Industry for Neurologic Condition Genetic Testing to 2025 - Featuring Ambry Genetics, Arup Laboratories & Asuragen Among Others

Share this article Share this article ResearchAndMarkets.com's offering. Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes for neurological conditions. The area of inherited condition testing for neurological conditions has b...

Global Hereditary Genetic Testing Markets, 2020-2030 - Technological Advancements for Exome Sequencing, Rise of DTC Testing Services & Massive Scope for Adoption of NGS-Based in Emerging Nations - Vimarsana News

Global Hereditary Genetic Testing Markets, 2020-2030 - Technological Advancements for Exome Sequencing, Rise of DTC Testing Services & Massive Scope for Adoption of NGS-Based in Emerging Nations

Global Hereditary Genetic Testing Market to Reach $67.39 Billion by 2030 Global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over the forecast period of 2020-2030. Hereditary genetic testing has grown significantly since the technology was first commercialized, but it is important to quantify that growth and describe future trends. The genome testing industry is proliferating, and its growth is expected to continue at its torrid pace. However, there are significant challenges that may dampen future growth if not addressed. The unmet clinical needs for better...